Conversely, during the transition to colon cancer, the expression of the STING pathway decreases, and its activation is associated with enhanced anti-tumor immune responses, such as increased infiltration of cytotoxic CD8+ T cells and reduced tumor invasiveness, correlating with better prognosis. Here, STING1 is linked to neoplasm.